540686 Stock Overview
Smruthi Organics Limited manufactures and markets active pharmaceutical ingredients (API) to pharmaceutical companies in India, Asia, Africa, the Americas, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Smruthi Organics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹159.00 |
| 52 Week High | ₹218.80 |
| 52 Week Low | ₹117.00 |
| Beta | 0.84 |
| 1 Month Change | 5.82% |
| 3 Month Change | -20.82% |
| 1 Year Change | 9.47% |
| 3 Year Change | -38.59% |
| 5 Year Change | 201.52% |
| Change since IPO | 173.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540686 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 3.4% | -2.5% | -2.5% |
| 1Y | 9.5% | 55.2% | 44.5% |
Return vs Industry: 540686 underperformed the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 540686 underperformed the Indian Market which returned 45.3% over the past year.
Price Volatility
| 540686 volatility | |
|---|---|
| 540686 Average Weekly Movement | 6.0% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 540686's share price has been volatile over the past 3 months.
Volatility Over Time: 540686's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 308 | Purushotham Eaga | www.smruthiorganics.com |
Smruthi Organics Limited manufactures and markets active pharmaceutical ingredients (API) to pharmaceutical companies in India, Asia, Africa, the Americas, and internationally. It API products include amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan for cardiovascular; metformin HCL, vildagliptin, teneligliptin, and dapagliflozin for anti-diabetic; ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate for anti-infective applications; and ticagrelor for anti-platelets. The company also offers drug intermediates, such as amlodipine base, s-amlodipine base, and phthaloyl amlodipine, as well as bulk drugs.
Smruthi Organics Limited Fundamentals Summary
| 540686 fundamental statistics | |
|---|---|
| Market cap | ₹1.82b |
| Earnings (TTM) | ₹27.61m |
| Revenue (TTM) | ₹1.25b |
65.9x
P/E Ratio1.5x
P/S RatioIs 540686 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540686 income statement (TTM) | |
|---|---|
| Revenue | ₹1.25b |
| Cost of Revenue | ₹692.51m |
| Gross Profit | ₹555.11m |
| Other Expenses | ₹527.50m |
| Earnings | ₹27.61m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.41 |
| Gross Margin | 44.49% |
| Net Profit Margin | 2.21% |
| Debt/Equity Ratio | 13.5% |
How did 540686 perform over the long term?
See historical performance and comparison